86 related articles for article (PubMed ID: 24270167)
1. Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.
Fisher BT; Kavcic M; Li Y; Seif AE; Bagatell R; Huang YS; Zaoutis T; Torp K; Leckerman KH; Aplenc R
Clin Infect Dis; 2014 Feb; 58(4):502-8. PubMed ID: 24270167
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia - A propensity-score matching analysis.
Silva WFD; Mendes FR; Melo RDCB; Velloso EDRP; Rocha V; Rego EM
J Mycol Med; 2023 Nov; 33(4):101434. PubMed ID: 37683564
[TBL] [Abstract][Full Text] [Related]
3. Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
Dvorak CC; Fisher BT; Sung L; Steinbach WJ; Nieder M; Alexander S; Zaoutis TE
Pediatr Blood Cancer; 2012 Jul; 59(1):21-6. PubMed ID: 22102607
[TBL] [Abstract][Full Text] [Related]
4. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.
Maude SL; Fitzgerald JC; Fisher BT; Li Y; Huang YS; Torp K; Seif AE; Kavcic M; Walker DM; Leckerman KH; Kilbaugh TJ; Rheingold SR; Sung L; Zaoutis TE; Berg RA; Nadkarni VM; Thomas NJ; Aplenc R
Pediatr Crit Care Med; 2014 Feb; 15(2):112-20. PubMed ID: 24366507
[TBL] [Abstract][Full Text] [Related]
5. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
Ho G; Wun T; Muffly L; Li Q; Brunson A; Rosenberg AS; Jonas BA; Keegan THM
Cancer; 2018 May; 124(9):1938-1945. PubMed ID: 29451695
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic.
Burns JE; Reyes Pérez D; Li Y; Gómez García W; Garcia FJ; Gil Jiménez JP; Sánchez J; Castillo Bueno M; Hunger SP; Reaves L; Contreras González J; Coffin SE; Deverlis A; Steenhoff AP; Fisher BT
PLoS One; 2020; 15(12):e0243795. PubMed ID: 33320881
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole and levofloxacin prophylaxis are ineffective strategies for preventing infections in acute myeloid leukemia patients undergoing chemotherapy.
Soldi LR; Silva MJB
Cancer Epidemiol; 2024 May; 91():102593. PubMed ID: 38815484
[TBL] [Abstract][Full Text] [Related]
8. Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia.
Ruiz J; Li Y; Cao L; Huang YV; Tam V; Griffis HM; Winestone LE; Fisher BT; Alonzo TA; Wang YJ; Dang AT; Kolb EA; Glanz K; Getz KD; Aplenc R; Seif AE
Cancer; 2024 Mar; 130(6):962-972. PubMed ID: 37985388
[TBL] [Abstract][Full Text] [Related]
9. Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol.
Supriyadi E; Purwanto I; Widiastuti Z; Armytasari I; Sandi S; Ardianto B; Kaspers GJL
Belitung Nurs J; 2024; 10(2):185-191. PubMed ID: 38690309
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial prophylaxis in pediatric patients with leukemia.
Al Omar S; Moumani D; Rihani R
Saudi Pharm J; 2018 Sep; 26(6):810-816. PubMed ID: 30202221
[TBL] [Abstract][Full Text] [Related]
11. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.
Halpern AB; Lyman GH; Walsh TJ; Kontoyiannis DP; Walter RB
Blood; 2015 Dec; 126(26):2790-7. PubMed ID: 26504183
[No Abstract] [Full Text] [Related]
12. Primary Mold-Active Antifungal Prophylaxis Decreases the Need for Chest Computed Tomography Scans in Patients with Acute Lymphoblastic Leukemia.
Karadaş N; Özdemir HH; Yilmaz Y; Göktepe ŞÖ; Ece D; Karapinar DY
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):196-203. PubMed ID: 38708155
[TBL] [Abstract][Full Text] [Related]
13. The impact of antifungal prophylaxis in patients diagnosed with acute leukemias undergoing induction chemotherapy: a systematic review and meta-analysis.
Soldi LR; Coelho YNB; Paranhos LR; Silva MJB
Clin Exp Med; 2023 Nov; 23(7):3231-3249. PubMed ID: 37058186
[TBL] [Abstract][Full Text] [Related]
14. Fungal infections in pediatric patients with acute myeloid leukemia in a tertiary hospital.
Ávila Montiel D; Saucedo Campos A; Avilés Robles M; Murillo Maldonado MA; Jiménez Juárez R; Silva Dirzo M; Dorantes Acosta E
Front Public Health; 2023; 11():1056489. PubMed ID: 37033052
[TBL] [Abstract][Full Text] [Related]
15. Neutropenia and Infection Prophylaxis in Childhood Cancer.
Villeneuve S; Aftandilian C
Curr Oncol Rep; 2022 Jun; 24(6):671-686. PubMed ID: 35230594
[TBL] [Abstract][Full Text] [Related]
16. Fungal diagnostic testing and therapy: navigating the neutropenic period in children with high-risk leukemia.
Fisher BT
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):361-367. PubMed ID: 34889439
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
Dvorak CC; Fisher BT; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L
J Pediatric Infect Dis Soc; 2021 Apr; 10(4):417-425. PubMed ID: 33136159
[TBL] [Abstract][Full Text] [Related]
18. Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia.
Miller LH; Keller F; Mertens A; Klein M; Allen K; Castellino S; Woods WG
Pediatr Blood Cancer; 2019 Dec; 66(12):e27975. PubMed ID: 31502412
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
